The practice of keeping healthy organs removed from donors’ bodies is known as organ preservation. The procedure entails removing the donor’s organs, transporting them in storage, and then safely transplanting them into the recipient’s body. It uses various procedures, including hypothermic machine perfusion, static cold storage (SCS), and normothermic machine perfusion (NMP), to keep the kidneys, liver, lungs, heart, and other organs at a constant temperature and oxygen saturation level. The methods and products employed for organ preservation are crucial for donor organ quality, which directly impacts the morbidity and survival rates of a patient following transplantation.
The market for organ preservation in 2021 was USD 206.89 million and will be worth USD 377.97 million growing at a 6.93% CAGR during 2021-2030.
The rising rate of chronic diseases and the expanding global geriatric population are the primary factors stimulating market expansion. The need for organ preservation operations is rising as a result of the frequent organ failures caused by serious medical illnesses like diabetes, obesity, cardiovascular disorders (CVDs), and others. The development of novel and cutting-edge methods for organ preservation, like NMP, is stimulating growth. Such methods improve the outcomes in cold storage for both clinical and experimental trials and help reduce the likelihood of reperfusion injury during transplantation. Additionally, the market growth is driven by an increase in government and non-government laws and initiatives to promote organ donation. The market is further driven by the growing number of people who volunteer to donate their organs for transplantation and research. Additional factors, such as increased research and development (R&D) and considerable improvements in the infrastructure for organ preservation, will also significantly impact market growth.
The increased cost of organ transplantation reduces consumer demand, which restrains the market’s expansion. According to a study, the average cost of a heart transplant, an intestinal transplant, and a bone marrow transplant in the USA in 2020 will be USD 1,664,800, USD 1,240,700, and USD 1,071,700, respectively. Patients are forced to look for alternative forms of treatment due to the exorbitant price of organ transplantation.
By solution, the market is segmented into perfadex, Custodial HTK, the university of Wisconsin, and others.
The University of Wisconsin (UW) held the greatest share in 2019 due to the solution’s increased utilization and several benefits. Additionally, it makes it simple to transfer organs safely over long distances. It primarily aids in liver preservation and raises the success percentage of liver transplantation. The rising liver transplantation rates will fuel market expansion.
On the basis of organ type, the market is segmented into lungs, kidneys, heart, liver, and others.
In 2019, the kidney market category had the biggest market share. The main factors impacting the market growth are the rising number of renal failure sufferers and kidney transplant surgeries worldwide. In the United States, around 37.00 million people have chronic kidney disease, and nearly 726,000 people each year have end-stage renal disease, according to a report released by the NHS in 2019. Various kidney transplant awareness campaigns will aid in segment expansion.
On the basis of preservation technique, the market is segmented into hypothermic machine perfusion, static cold storage, normothermic machine perfusion, and others.
Due to its broad applicability and rising use, the static cold storage category had the greatest share in 2019. The main purpose of static cold storage is kidney preservation. But it is also employed in the preservation of other organs. Additionally, the existence of numerous market participants who provide static cold storage will foster the segment’s expansion.
Over the projected period, the normothermic machine perfusion segment will grow at the fastest CAGR. This method gives the organ enough nourishment and oxygen to support aerobic metabolism. Additionally, it lowers the possibility of post-transplant side effects and contributes to better transplant results.
In 2019, North America contributed to the biggest market share. The main drivers of growth are the increasing acceptance of cutting-edge healthcare technologies, the high prevalence of chronic renal disease and heart failure, improved reimbursement rules, and rising investments in expanding healthcare infrastructure. The regional market will rise due to the aging population and an increase in organ transplant surgeries.
Due to rising healthcare costs, patient awareness, and growing demand for organ transplant procedures, Asia Pacific will experience the fastest increase throughout the projection period. In the years to come, the aging population, increased kidney and heart failure rates, and rising healthcare expenses will contribute to the market’s expansion.
- Paragonix Technologies
- Dr. Franz Köhler Chemie GmbH
- XVIVO Perfusion AB
- Essential Pharmaceuticals, LLC
- Bridge To Life Limited
- OrganOx Limited
- 21st Century Medicine
- Shanghai Genext Medical Technology
- Preservation Solutions
- Waters Medical Systems
- Transplant Biomedicals
- Institut Georges Lopez
- Global Transplant Solutions
- Organ Preservation Solutions
- TX Innovations
- Vascular Perfusion Solutions
The market for organ preservation in 2021 was USD 206.89 million and will be worth USD 377.97 million growing at a 6.93% CAGR during 2021-2030. Among the main drivers propelling the market’s expansion are the rising rate of chronic diseases and the expanding global geriatric population.